Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients

Michael Retsky¹ , Gianni Bonadonna², Romano Demicheli² , Judah Folkman¹, William Hrushesky³ and Pinuccia Valagussa²

¹Department of Surgical Research, Children's Hospital and Harvard Medical School, Boston, MA, USA

²Department of Medical Oncology, Milan National Cancer Institute, Milan, Italy

³Dorn Veterans Affairs Medical Center and University of South Carolina School of Medicine, Columbia, SC, USA

author email corresponding author email

Breast Cancer Res 2004, 6:R372-R374doi:10.1186/bcr804


Published:	14 May 2004

See related Commentary: http://breast-cancer-research.com/content/6/4/160

Abstract

Background

We suggest that surgical extirpation of primary breast cancer among other effects accelerates relapse for some premenopausal node-positive patients. These accelerated relapses occur within 10 months of surgery for untreated patients. The mechanism proposed is a stimulation of angiogenesis for distant dormant micrometastases. This has been suggested as one of the mechanisms to explain the mammography paradox for women aged 40–49 years. We could imagine that it also plays a role in adjuvant chemotherapy effectiveness since, perhaps not coincidentally, this is most beneficial for premenopausal node-positive patients.

Hypothesis

We speculate that there is a burst of angiogenesis of distant dormant micrometastases after surgery in approximately 20% of premenopausal node-positive patients. We also speculate that this synchronizes them into a temporal highly chemosensitive state and is the underlying reason why adjuvant chemotherapy works particularly well for that patient category. Furthermore, this may explain why cancer in younger patients is more often 'aggressive'.

Testing the hypothesis

Stimulation of dormant micrometastases by primary tumor removal is known to occur in animal models. However, we need to determine whether it happens in breast cancer. Transient circulating levels of angioactive molecules and serial high-resolution imaging studies of focal angiogenesis might help.

Implications

Short-course cytotoxic chemotherapy after surgery has probably reached its zenith, and other strategies, perhaps antiangiogenic methods, are needed to successfully treat more patients. In addition, the hypothesis predicts that early detection, which is designed to find more patients without involved lymph nodes, may not be a synergistic strategy with adjuvant chemotherapy, which works best with positive lymph node patients.